Skip to Content
Cancer Therapy Evaluation Program (CTEP)
Last Updated: 11/07/16

Staff, Pictures and Bios

Meg Mooney, MD, MBA, Branch Chief, CIB, Head — Adult Sarcoma/Melanoma

Meg Mooney, MD, MBA is the Chief of the Clinical Investigations Branch (CIB) of the Cancer Therapy Evaluation Program (CTEP), Division of Cancer Treatment and Diagnosis, at the NCI and oversees adult sarcoma cancer therapeutics. She was formerly the Interim Director of the Office of Evidence-Based Surgery at the American College of Surgeons in Chicago, Illinois. More…

Malcolm A. Smith, MD, PhD, Associate Branch Chief for Pediatric Oncology

Dr. Smith is Associate Branch Chief, Pediatrics in the Clinical Investigations Branch [Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI)]. More…

Dr. Carmen Allegra, MD, Head — GI Cancer Therapeutics

Dr. Carmen Allegra joined the Clinical Investigations Branch (CIB), CTEP, DCTD to provide expertise and oversight of the GI cancers clinical trials portfolio under an interagency agreement between NCI and the University of Florida where he is Chief of the Division of Hematology and Oncology. More…

Andrea M. Denicoff, RN, MS, ANP, Head, NCTN Clinical Trials Operations & Scientific Liaison, Patient Reported Outcomes (PROs)

Andrea Denicoff is a Nurse Consultant in the Clinical Investigations Branch within the Cancer Therapy Evaluation Program (CTEP) in the Division of Cancer Treatment & Diagnosis at the National Cancer Institute (NCI). She serves as the Head of Clinical Trials Operations for the NCI's National Clinical Trials Network (NCTN). More…

Elise C. Kohn, MD, Head — Gynecologic Cancer Therapeutics

To promote scientifically driven and practice-changing trials, Dr. Kohn reviews, coordinates, and oversees development and execution of phase 2-3 trials in gynecologic cancers and gastrointestinal neuroendocrine cancers. She also provides disease expertise for early phase trials in these cancers. Dr. Kohn also applies her expertise to the oversight and guidance of the NCTN Core Correlative Science Committee (CCSC). More…

Dr. Larissa Korde, MD, Head — Breast Cancer Therapeutics

Dr. Larissa Korde joined the Clinical Investigations Branch, CTEP, DCTD, in September 2016 to provide expertise and oversight of the Breast Cancers clinical trials portfolio. More…

Richard F. Little, MD, Head — Hematologic, HIV, and Stem Cell Therapeutics

Dr. Little Joined CTEP as Head of the therapeutics section for Hematologic and AIDS-related Cancers and Hematopoietic Stem Cell April 2007. More…

Shakun Malik, MD, Head — Thoracic Cancer Therapeutics

Dr. Shakun Malik joined the National Cancer Institute's (NCI) Cancer Therapy Evaluation Program in November 2013 as the head of thoracic oncology therapeutics. Her goal is to facilitate lung cancer research. Prior to joining CTEP, Dr. Malik worked at the U.S. Food and Drug Administration (FDA), where she gained valuable experience in understanding the regulatory pathways that make drugs available to patients. More…

Bhupinder Mann, MBBS, Head — Genitourinary and Brain Cancer Therapeutics

Dr. Bhupinder Mann joined the Clinical Investigations Branch at CTEP in September 2008. He has the Genitourinary and the Adult Brain Cancers therapeutic clinical trials portfolio. He is the assigned CIB scientific liaison to the NCTN NRG group. More…

Grace Mishkin, MPH, Public Health Analyst

Grace Mishkin joined the Clinical Investigations Branch in CTEP as a Public Health Analyst in July 2016. She provides operational support for NCI's National Clinical Trials Network and coordinates several cross-cutting projects around clinical trials at NCI. More…

Nita L. Seibel, MD, Head — Pediatric Solid Tumors

Dr. Nita L. Seibel, a board certified pediatric hematologist-oncologist is the head of the Pediatric Solid Tumor Therapeutics in the Clinical Investigations Branch of the Cancer Therapy and Evaluation Program of the National Cancer Institute. More…

Andrew Marshall, Administrative Assistant

Georgia Washington, Administrative Assistant

About the Branch Chief

Meg Mooney, MD Meg Mooney, MD, MBA is the Chief of the Clinical Investigations Branch (CIB) of the Cancer Therapy Evaluation Program (CTEP), Division of Cancer Treatment and Diagnosis, at the NCI and oversees adult sarcoma cancer therapeutics. She was formerly the Interim Director of the Office of Evidence-Based Surgery at the American College of Surgeons in Chicago, Illinois. More…